nPhase lands $30M Series D for AI-native clinical data platform – Dealroom

nPhase has secured $30 million in Series D funding for its AI-native clinical data platform. The funding round supports the company’s efforts to advance its technology for processing and managing clinical data through artificial intelligence. Details regarding the specific use of proceeds and participating investors were not provided in the announcement.

Read Full Article →